News

Medscape20h
How Proposed Tariffs Could Disrupt US Drug Prices and Supply
Health policy experts say the tariffs would raise prices for patients, potentially disrupt supply, and could hurt the US ...
Fierce Pharma1d
Senators bring back bill to bolster US pharma supply chain by awarding contracts to domestic producers
Four U.S. senators have reintroduced a bipartisan bill focused on strengthening the pharmaceutical supply chain by ...
NIPTE Celebrates 20 Years Of Advancing US Pharmaceutical Development And Manufacturing, Initiates New Industry Collaboration And Workforce Development Efforts
NIPTE continues its long-held mission to promote quality and availability of medicines in the US. MINNEAPOLIS, June 18, 2025 /PRNewswire/ ...
U.S. judge upholds FDA's removal of Ozempic, Wegovy from drug shortage list
A federal judge in Texas has upheld the U.S. Food and Drug Administration's decision to remove Novo Nordisk's blockbuster ...
Health Affairs8d
Podcast: Keith Drake on How Authorized Generics Shape Drug Competition
Health Affairs' Rob Lott interviews Keith Drake of Greylock McKinnon Associates about his recent paper that explores trends ...
The Manila Times5d
US FDA OKs removal of Mang Tomas, UFC, Jufran from Import Alert 99-45
THE US Food and Drug Administration (US FDA) officially approved Nutriasia's petition to remove Mang Tomas All Purpose Sauce, ...
CapRadio6d
Online sales of obesity drug alternatives carry on despite FDA deadlines
Since the FDA said shortages of Wegovy and Zepbound are over, compounding pharmacies are supposed to stop making copies of the drugs. But some of those business are trying to find ways to continue.
Manila Standard9d
OUT OF THE RED – US FDA Approves Petition To Remove Mang Tomas, UFC, Jufran from Import Alert 99-45
The US Food and Drug Administration (US FDA) has officially approved Nutriasia’s petition to remove Mang Tomas All Purpose Sauce, Jufran Banana Sauce, and ...